Wednesday, September 20, 2017 6:20:39 AM
Ignoring the nutty conspiracy talk about mysterious behind the scenes players called 'Rick' and 'Chris'....
One has to wonder why anyone would think this stock 'is about to move up'.
* Everything listed on the MEDT Investors Hub page about this company is dead information or just a plain lie - consulting, grow lights, packaging, pesticide and chemical research. Not a single one of these claimed items has any reality or has MEDT management made any mention of them for years
* The one product that actually exists, the BlazeNow weedmaps clone, is dead. Anyone can see for themselves no one uses the website or mobile app. The latest mobile app version had only seven reviews last I checked. Both the mobile app and website are poorly made and don't work very well.
* There has been some vague claims about CBDs. It has been a year and there is zero evidence anything is real. No pictures of company sites. No quotes from the key people involved. Nothing.
That's it. MEDT is clearly a company run by people who have no idea what they are doing.
And finally, the silly 'letter of intent' news. That might be mildly interesting if it was actually two revenue generating companies with viable business plans.
MEDT is a dead company with a single failed product. In other words they have nothing of value to add to any partnership. And they don't even have a partnership. Just some worthless document saying they are talking with some other company. Nothing.
No profits.
No revenue.
No concrete plans to generate revenue.
No management changes.
Zero interest from anyone other than the usual small time buyers who are foolish enough to try for a random +20 percent pop. This stock could easily collapse. There is no value to support any price above zero.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM